Making biologics affordable and accessible for all patients

With our innovative continuous process we are creating a unique licensing proposition for CDMOs and biopharma companies.

BiosanaPharma is transforming the production of mAb biologics  with a continuous process that is scalable, flexible, authority approved and positioned to reduce manufacturing CoGs for biologics and biosimilars by >90%.